0001493152-24-025105.txt : 20240625 0001493152-24-025105.hdr.sgml : 20240625 20240625163247 ACCESSION NUMBER: 0001493152-24-025105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240621 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gurrola Sandra M CENTRAL INDEX KEY: 0001618457 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 241069365 MAIL ADDRESS: STREET 1: 2231 RUTHERFORD ROAD STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eterna Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 18A CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 10531 4S COMMONS DRIVE STREET 2: SUITE 166-550 CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0508 4 2024-06-21 0 0000748592 Eterna Therapeutics Inc. ERNA 0001618457 Gurrola Sandra M C/O ETERNA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, SUITE 18A CAMBRIDGE MA 02141 0 1 0 0 Sr. VP of Finance 0 Common Stock 2024-06-21 4 M 0 437 A 1365 D Common Stock 2024-06-21 4 F 0 180 1.94 D 1185 D Restricted Stock Units 2024-06-21 4 M 0 437 0 D Common Stock 437 437 D Each restricted stock unit converts into one share of common stock. On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date. /s/ Sandra Gurrola 2024-06-25